Author:
Flather Marcus D.,Kotecha Dipak
Reference38 articles.
1. Böhm M, Werner C, Jakobsen A, Heroys J, Ralph A, Rees T, Shaw M (2008) Treating to protect: current cardiovascular treatment approaches and remaining needs. Medscape J Med 10(Suppl):S3
2. Ebrahim S, Beswick A, Burke M, Davey Smith G. (2006) Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev (4):CD001561. Review.
3. Sanz G, Fuster V (2009) Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population. Nat Clin Pract Cardiovasc Med 6(2):101–110 Epub 2008 Dec 23
4. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–952
5. Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71–86